Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis

Hepatology

Volumn 55, Issue 6, 2012, Pages 1931-1941

  Sancho Bru, Pau ^a   Altamirano, José ^a   Rodrigo Torres, Daniel ^a   Coll, Mar ^a   Millán, Cristina ^a   José Lozano, Juan ^a   Miquel, Rosa ^b   Arroyo, Vicente ^a   Caballería, Juan ^a   Ginès, Pere ^a   Bataller, Ramon ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; CELL PROTEIN; CREATININE; CYTOKERATIN 19; CYTOKERATIN 7; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; PROMININ 1; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADULT; AGE; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MORTALITY; POLYMORPHONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME;

ANTIGENS, CD; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; FEMALE; GLYCOPROTEINS; HEPATITIS, ALCOHOLIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; LIVER; MALE; MIDDLE AGED; PEPTIDES; SEVERITY OF ILLNESS INDEX; STEM CELLS;

EID: 84861576624     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25614     Document Type: Article

References (33)

1. Elphick DA, Dube AK, McFarlane E, Jones J, Gleeson D. Spectrum of liver histology in presumed decompensated alcoholic liver disease. Am J Gastroenterol 2007; 102: 780-788.
2. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346: 987-990.
3. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. HEPATOLOGY 1997; 25: 108-111.
4. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769.
5. Dominguez M, Rincon D, Abraldes JG, Miquel R, Colmenero J, Bellot P, et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008; 103: 2747-2756.
6. Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology 2009; 137: 466-481.
7. Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008; 322: 1490-1494.
8. Roskams T, Katoonizadeh A, Komuta M. Hepatic progenitor cells: an update. Clin Liver Dis 2010; 14: 705-718.
9. Eleazar JA, Memeo L, Jhang JS, Mansukhani MM, Chin S, Park SM, et al. Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J Hepatol 2004; 41: 983-991.
10. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. HEPATOLOGY 2004; 39: 1739-1745.
11. Turner R, Lozoya O, Wang Y, Cardinale V, Gaudio E, Alpini G, et al. Human hepatic stem cell and maturational liver lineage biology. HEPATOLOGY 2011; 53: 1035-1045.
12. Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human livers: symmetry between development and regeneration. HEPATOLOGY 2008; 48: 1598-1607.
13. Bateman AC, Hubscher SG. Cytokeratin expression as an aid to diagnosis in medical liver biopsies. Histopathology 2010; 56: 415-425.
14. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 2000; 192: 373-378.
15. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542-2556.
16. Suzuki A, Sekiya S, Onishi M, Oshima N, Kiyonari H, Nakauchi H, et al. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. HEPATOLOGY 2008; 48: 1964-1978.
17. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204: 1973-1987.
18. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136: 1012-1024.
19. Yoon SM, Gerasimidou D, Kuwahara R, Hytiroglou P, Yoo JE, Park YN, et al. Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. HEPATOLOGY 2011; 53: 964-973.
20. Duret C, Gerbal-Chaloin S, Ramos J, Fabre JM, Jacquet E, Navarro F, et al. Isolation, characterization, and differentiation to hepatocyte-like cells of nonparenchymal epithelial cells from adult human liver. Stem Cells 2007; 25: 1779-1790.
21. Sancho-Bru P, Najimi M, Caruso M, Pawelyn K, Cantz T, Forbes SJ, et al. Stem and progenitor cells for liver repopulation: can we standardize the process from bench to bedside? Gut 2009; 58: 594-603.
22. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis 2003; 23: 385-396.
23. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154: 537-541.
24. Jung Y, Brown KD, Witek RP, Omenetti A, Yang L, Vandongen M, et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 2008; 134: 1532-1543.
25. Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163: 1301-1311.
26. Ginès P, Lenz K, Møller S, Moore K, Moreau R, Merkel C, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
27. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. HEPATOLOGY 2007; 46: 922-938.
28. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. HEPATOLOGY 2009; 49: 2087-2107.
29. Dominguez LJ, del Castillo AL, Miquel R, Colmenero J, Moreno M, Garcia-Pagán JC, et al. Identification of Fn14, a TNF receptor super-family member, as a therapeutic target in patients with alcoholic hepatitis. HEPATOLOGY 2009; 50: 600A-705A.
30. Muller R, Mockel M. Logistic regression and CART in the analysis of multimarker studies. Clin Chim Acta 2008; 394: 1-6.
31. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. HEPATOLOGY 2005; 41: 353-358.
32. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54: 1174-1179.
33. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199.